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ABSTRACT 
Assessment of the dielectrophoresis (DEP) cross-over frequency (fxo), cell diameter and 
derivative membrane capacitance (Cm) values for a group of undifferentiated human embryonic 
stem cell (hESC) lines (H1, H9, RCM1, RH1), and for a transgenic subclone of H1 (T8) revealed 
that hESC lines could not be discriminated on their mean fxo and Cm values, the latter of which 
ranged from 14-20 mF/m2. Differentiation of H1 and H9 to a mesenchymal stem cell-like 
phenotype resulted in similar significant increases in mean Cm values to 41-49 mF/m2 in both 
lines (p<0.0001). BMP4-induced differentiation of RCM1 to a trophoblast cell-like phenotype 
also resulted in a distinct and significant increase in mean Cm value to 28 mF/m2 (p<0.0001). The 
progressive transition to a higher membrane capacitance was also evident after each passage of  
cell culture as H9 cells transitioned to a mesenchymal stem cell-like state induced by growth on a 
substrate of hyaluronan. These findings confirm the existence of distinctive parameters between 
undifferentiated and differentiating cells on which future application of dielectrophoresis in the 
context of  hESC manufacturing can be based.   
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I. INTRODUCTION 
Human embryonic stem cells (hESCs) isolated from early blastocyst stage embryos1,2 and 
comparably pluripotent stem cells induced from adult cells by gene transduction3 (iPSCs) 
constitute a promising resource for disease modeling, drug screening and cell therapies for 
regenerative medicine. This is founded on their immortality and pluripotency, as compared to the 
restricted growth potential and repertoires of adult tissue-sourced stem cells. However, the 
breadth of this capacity also makes controlling cell behavior in vitro more difficult, potentially 
undermining their utility due to variable and heterogeneous cell production and the difficulty of 
distinguishing cells of a desired phenotype from other contaminating populations. Thus, to 
achieve standardized production of the quantity and type of cells desired for particular 
applications there is a need for sensitive and non-invasive methods to discriminate and ultimately 
segregate live cell populations. 
 
Dielectrophoresis (DEP) is a well studied electrokinetic technique4-7 which has been used to 
discriminate between distinct cellular identities in heterogeneous populations, notably 
haematopoietic stem cells and differentiated derivatives in bone marrow and blood8,9, 
mesenchymal stem cells in adipose tissue10, and neural stem cell populations11,12. A DEP device 
for antibody-independent capture of viable circulating cancer cells in blood has already been 
developed13, and theoretically DEP could provide a simple and non-invasive way to positively or 
negatively select for target or contaminating cell types in a cell preparation intended for 
transplantation.  The DEP response of a cell involves either movement up a field gradient 
towards an electrode (positive DEP) or down a field gradient away from an electrode (negative 
DEP). A transition between these two responses occurs where the effective polarisability of the 
cell matches that of the surrounding medium, and this can occur at both a low frequency (kHz 
range) or high frequency (>100 MHz). In the kHz range explored in this work the corresponding 
DEP cross-over frequency fxo for a spherical cell of radius r is given to good approximation by:   
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where Cm is the specific capacitance of the cell membrane and σm is the conductivity of the 
suspending medium7.   
 
Measurement of fxo and Cm has been shown to provide a sensitive, non-invasive way to monitor 
changes in cell states associated with activation and clonal expansion, apoptosis, necrosis and 
responses to chemical and physical agents14-17. As such, DEP could be applied in the context of 
stem cell processing as a means for real-time characterisation of the identity and viability of 
manufactured cell preparations. 
 
Recently the application of DEP to neural stem cell populations suggested that the differentiation 
fate of neural stem cells could be predicted by distinct changes in their fxo and Cm values before 
the presence of specific cell-surface proteins (antigens) could be detected12,13. In the present 
study our objective was to evaluate DEP as a means to discriminate and characterize 
undifferentiated hESCs and differentiating progeny. This is an important prerequisite to an 
ambition to use DEP in the context of manufacturing hESC derived cell products given variation 
which can exist between cell lines in the course of adaptation to culture or genetic modification. 
Using the aforementioned equation (1), we measured fxo and derive Cm values in several 
undifferentiated hESC lines (H1, H9, RCM1, RH1)18-21, a transgenic clonal derivative (T8; a 
subclone of H1 expressing a genome-integrated Green Fluorescent Protein reporter (GFP) under 
the control of the OCT4-pluripotency associated transcription factor promoter)21 , and derivatives 
of these cell lines to multipotent-mesenchymal-stem cell like cells22 and to trophoblast23. Our 
findings confirm the existence of distinctive parameters of undifferentiated and differentiating 
cells on which future application of DEP in hESC manufacturing can be based.   
 
II. MATERIALS AND METHODS 
A. Cell culture 
The use of hESC lines in this project was approved by the MRC steering committee 
overseeing the UK Stem Cell Bank.  RCM1 and RH1 were derived at the Roslin Institute under a 
license from the Human Fertilisation and Embryology Authority to P. De Sousa and licensed 
from Roslin Cells and Geron, respectively. Both cell lines have been deposited in the UKSCB 
(www.ukstemcellbank.org.uk). H1 and H9 were derived first at Wisconsin Regional Primate 
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Research Center, University of Wisconsin and licensed from WiCell. They are available from the 
Wisconsin International Stem Cell Bank (www.wicell.org). The T8 cell line was derived at the 
Roslin Institute by transfecting the H1 hESC cell line with an octamer-binding transcription 
factor 4-GFP (OCT4-GFP) reporter.  
 
RCM118, RH119, H1 and H920, and T821 hESCs were cultured on plastic tissue culture plates 
(Corning inc. NY) coated with growth factor-reduced MatrigelTM (Becton Dickinson) at 37 oC, 
5% CO2. T8 hESCs were cultured in mTeSR1 medium (Stemcell Technologies) supplemented 
with 100 µg ml-1 G418 (Gibco)21. RCM1, RH1, H1 and H9 hESCs were cultured in mTeSR1 
alone. Cells were routinely passaged using 200 units/ml of collagenase in Knockout Dulbecco’s 
modified Eagle medium (KO-DMEM, Invitrogen) followed by manual scraping.  
 
H1 and H9 hESCs were differentiated to a mesenchymal stem cell like phenotype using an 
established protocol involving successive passaging on a substrate of hyaluronan, also known as 
hyaluronic acid or hyaluronate22, in a human dermal fibroblast conditioned medium (HDF-CM) 
composed of KO-DMEM, 20% Knockout serum replacement (KOSR, Invitrogen), 1mM 
glutamine, 0.1 mM β-mercaptoethanol and 4 ng/ml bFGF, prepared as described previously17. 
Mesenchymal stem cell-like lines originating from H1 and H9 were designated H1-MSC and 
H9-MSC, respectively. A stock solution of hyaluronan (HA; 1200kD, Proud.385908, Merck-
Calbiochem, Nottingham, UK) was produced by solubilising it in physiological strength 
phosphate buffered saline (PBS) at 10 mg/ml and used for substrate coating. Tissue culture wells 
were coated with HA stock solution applied at 0.1 ml/cm2 for 30 min at 4oC before warming to 
room temperature and grown in 80% KO-DMEM and 20% KOSR (Gibco). For trophoblast cell 
differentiation, RCM1 hESCs were cultured on MatrigelTM (Becton Dickinson) coated plastic 
tissue culture plates in HDF-CM18 further supplemented with bone morphogenetic protein 
(BMP4) at 100ng/ml for 7 days as described previously23. These cells were designated RCM1-
trophoblast. 
 
For immunolabeling, both hESCs and differentiated cells were washed in PBS buffer and fixed 
with 4% paraformaldehyde PFA, permeabilised with 0.2% igepal (Sigma) and blocked in 10% 
rabbit serum (Millipore). Fixed and permeabilised hESCs were incubated with, mouse anti-
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OCT4 (dilution 1:50, Santa Cruz Biotechnology). Primary antibody binding was detected by 
incubating with rabbit anti-mouse Alexa-Fluor-488 (dilution 1:200, Invitrogen); nuclei were 
counterstained with DAPI24 (Roche). Fixed and permeabilised HA-differentiated cells were 
washed in PBS and stained to detect mesenchymal markers by incubating with goat anti-human 
CD105 (1:50 dilution, R&D Systems), and mouse anti-human STRO-1 (1:200 dilution, 
Millipore). Secondary antibodies were donkey anti-goat Alexa-Fluor-555  (1:400 dilution, 
Invitrogen), and rabbit anti-mouse Alexa-Fluor-488 (1:200 dilution, Invitrogen), respectively.  
Fixed and permeabilised RCM1-trophoblast cells were washed in PBS and incubated with mouse 
anti-human CDX2 (1:50 dilution, Vector labs) and mouse anti-hCG-β (1:25 dilution, Abcam). 
Primary antibodies were detected by incubating with goat anti-mouse Alexa-Fluor-488 
(dilution 1:200, Invitrogen) and nuclei were counterstained with DAPI24 (Roche).  Images were 
captured with a Zeiss Observer microscope and Nikon camera. 
 
B. Osteoblast formation 
 Osteogenic differentiation was induced as previously described by Sottile et al25. An 
osteogenic (OS) supplement consisting of 50 µM ascorbic acid phosphate (Wako, Neuss, 
Germany), 10 mM β-glycerophosphate (Sigma-Aldrich, Dorset, UK), and 100 nM 
dexamethasone (Sigma-Aldrich, Dorset, UK) was added to DMEM medium.  Cells grown 
previously on HA (H1) for 10 passages were plated on 0.1% gelatin and treated with embryoid 
body differentiation (EBD) medium consisting of 80% KO-DMEM (Invitrogen), 20% FBS 
(PAA Laboratories, Pasching, Austria), 1 mM L-glutamine, 0.1 mM µ-mercaptoethanol, 1 % 
nonessential amino acids (all Invitrogen) +/- OS that was changed every 2 days over the 
indicated intervals. 
Mineralisation analysis 
 For mineralized nodule detection, fixed wells of cells were washed twice with calcium and 
magnesium-free (CMF)-PBS before incubation with a 1% Alizarin-Red S (Sigma-Aldrich, 
Dorset, UK) solution in CMF-PBS for 10 min. This was followed by washing twice with water 
and then fixation in 95% methanol. Cell matrix–associated calcium deposition was determined in 
96-well plates using the Sigma calcium assay kit (Sigma-Aldrich, Dorset, UK), in triplicate wells. 
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C. Flow Cytometry 
 Single cell suspensions of cultured cells were prepared by treatment with Trypsin-EDTA 
(Gibco Invitrogen, Paisley, UK) for 5-10 min at 37oC followed by re-suspension in FACS PBS 
(PBS with 0.1% bovine serum albumin [BSA]). Cells were incubated for 20 min at 4oC with pre-
conjugated MSC markers CD73-PE (BD Biosciences), CD105-FITC, CD90-FITC, Stro1-APC, 
CD34-PE (BD Biolegend) and CD14-PE (Becton Dickson). To remove unbound antibody, 2 mls 
of FACS PBS were added per aliquot, and decanted after centrifugation at (1300 rpm) for 5 min. 
Cell samples finally resuspended in 250µl FACS PBS and analyzed using a flow cytometer 
(FACSCalibur Becton Dickinson) equipped with 488nm and 633nm lasers and standard filter set.  
FACS data was analyazed and plotted using FCS Express software. 
 
D. DEP studies 
 DEP cross-over frequencies fxo for individual cells were obtained using the electrode design 
shown in Figure 1. The electrodes were fabricated using standard photolithography and liftoff 
techniques, and consisted of gold (150 nm) thermally evaporated onto a chrome adhesion layer 
(5 nm) and patterned into an interdigitated array on a glass substrate. The electrode substrate 
formed the floor of an open chamber, of internal length 10 mm, width 10 mm and height 80 µm, 
constructed from polydimethylsiloxane (PDMS) bonded onto the glass substrate containing the 
electrodes. The spatial variation of the field non-uniformity generated by this interdigitated 
electrode design, characterized by the factor 2E∇ , was modeled using COMSOL (Multiphysics 
4.3) finite element software. This information was used to derive the magnitude of the DEP force 
acting on typical cells as a function of the applied sinusoidal voltage and location above the 
electrode plane.  An example of this modelling is shown in Figure 1. The maximum Brownian 
diffusional force (kT/2r) acting on a cell of radius 5 µm at room temperature is 4 x 10-16 N, and 
from Figure 1 the corresponding DEP force for an applied voltage of 3 V(pk) greatly exceeded 
this value. However, the sedimentation force acting on a 5 µm radius cell can be estimated as 2 x 
10-13 N (assuming a specific density difference of 40 kg/m3 between the medium and cell). To 
ensure that sedimentation forces did not influence the assessment of the DEP force when close to 
fxo, studies were limited to those cells located no higher than 20 µm above the electrode plane.   
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Before DEP characterization the cells were centrifuged (100 x g, 5 minutes) and washed twice in 
10 ml of the DEP medium, before final suspension in this medium at a density of ~107 cells/mL.  
The DEP isotonic medium consisted of 8.5% (w/w) sucrose, 0.5% (w/w) glucose, at pH 7.4 
(adjusted with NaOH) and conductivity 33 mS/m, adjusted with phosphate buffered saline (PBS). 
Osmolality (310 mOsm) and conductivity values were measured using an osmometer (Advanced 
Instruments Inc., Model 3300) and a conductivity meter (Oakton CON 510), respectively. Cell 
suspensions were pipetted onto the electrodes, the chamber was closed with a cover slip and then 
mounted in an inverted microscope (Meiji TC5100). Sinusoidal voltages of 3 V(pk) were applied 
to the electrodes in continuous incremental steps of 10 kHz, commencing at 10 kHz and finishing 
at 200 kHz, using an Agilent/HP 3325A signal generator. By focusing on the electrode plane 
discrimination between cells undergoing negative DEP and positive DEP was possible, and an 
estimation of fxo was made for each cell by analysis of video images captured during this 
procedure. The diameter of each characterized cell was measured using Free Ruler 
(www.pascal.com/software/freeruler).  
 
E. Statistical Analysis 
Statistical analyses (unpaired t-tests or one-way ANOVA with Tukey's post-hoc test, as 
appropriate) were performed in GraphPad Prism, version 6.  
 
III. RESULTS AND DISCUSSION 
 
The undifferentiated phenotype and pluripotency of hESC lines used in this study has been 
reported in previous studies18-21. Flow cytometry confirmed all lines were positive for 
undifferentiated glycolipids SSEA-4 and TRA-1-60, and negative for SSEA-1 (Table 1). The 
former were lower in the transgenic GFP reporter-expressing T8 line. By in situ 
immunocytochemistry undifferentiated cell colonies in all lines were positive for pluripotency 
associated transcription factors, Oct4 and Nanog (Oct4 shown for H1, Figure 2A). H1 and H9 
hESC’s were differentiated to MSC-like lineages as previously reported in Harkness et al22. 
Consistent with an adult tissue derived MSC flow cytometry confirmed cells were CD73+, 
CD105+, CD90+, and Stro1+ and CD14-, CD34- (Shown for H1, Figure 3). CD105 and Stro1 
expression was confirmed by immunocytochemistry (Figure 2 B). To confirm an MSC-like 
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potency, cells were induced to undergo mineralization in vitro in response to an osteogenic 
stimulus (OS) as previously described by Sottille et al25. H1-MSC grown on HA for 10 passages 
underwent OS dependent mineralization characteristic of osteoblast-like cells. This was reflected 
by Alazarin Red staining and calcium deposition, (Figure 4), both of which increased over 
successive days of stimulation and were maximal by 10 days of treatment respectively.  RCM1 
cells were non-specifically differentiated to yield heterogeneous populations of trophoblast like 
cells using another established protocol Xu et al23. This was verified by immunostaining for 
CDX2 and hCG-β markers (Figure 2 c, d). 
 
A summary of the experimentally measured cell diameters and DEP cross-over frequencies (fxo) 
for the various hESCs and their differentiated progeny is given in Table 2, together with their 
membrane capacitances derived using equation (1). The standard deviation (σ = 1) values given 
are based on approximating the fxo and Cm distributions shown in Figure 5 as normal 
distributions. The results presented in Table 2 and Figure 5 indicate that there is a significant 
overlap of the membrane capacitance values for the different hESC lines, with an overall mean 
value of 17.6 ± 4.7 mF/m2. The overlap of the fxo distributions shown in Figure 5 (a) indicates 
that (apart from with H9) it would not be possible to obtain pure samples of different hESC lines 
from a mixed population using DEP as a separation tool. High purity separation of H9 cells from 
a mixture of H1 and H9 cells, for example, could be obtained using the DEP device described by 
Gupta et al13 at 120 kHz with a cell medium conductivity of 35 mS/m, but with a recovery of less 
than 50% for the H9 cells.  
 
From Figure 6 it is also clear that H1 and H9 cells both exhibited well-separated distributions of 
their fxo values, with little overlap, compared to those exhibited by their differentiated progeny 
(H1-MSC and H9-MSC, respectively). Separation of pure populations of differentiated cells 
from their progenitor H1 or H9 cells, with relatively high yields, should therefore be possible 
using DEP. However, DEP is unlikely to provide a sensitive method for distinguishing 
populations of RCM1-trophoblast from RCM1 ES cells. Coupled with the distinct separation of 
fxo distributions after differentiation, the results shown in Figures 6 & 7 indicate that there is also 
a distinct increase of cellular membrane capacitance values (p<0.0001). H1-MSCs and H9-MSCs 
exhibit a broad distribution of Cm values, extending from around 30 to 70 mF/m2, compared to 
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the more narrow ranges centered near 17 and 14 mF/m2 exhibited by the H1 and H9 cells, 
respectively. Although the RCM1 and RCM1-trophoblast exhibit a clear difference in their mean 
Cm value (~ 18 mF/m2 and 28 mF/m2, respectively), there is a significant overlap of their Cm 
distributions. Finally, the changes in membrane capacitance and cell diameter for H9 cells as 
they are differentiated into H9-MSCs are shown in Figure 8 as a function of passage number. 
There is no statistical difference in cell diameter between H9 and H9-MSCs at passage 2 and 
passage 3 (p>0.05).  However, there is a small but significant difference in diameter when H9 
cells are compared to H9-MSCs at passage numbers 4-9 (p<0.05). Although the cell size 
increases by 12.4% from H9 to H9-MSC (p9), the observed change in the cross-over frequency 
can be primarily attributed to a significant increase in membrane capacitance of 247 % 
(p<0.0001). 
 
It is customary to employ the low-frequency (DC) approximation26 to analyse the dielectric and 
conductive properties of a cell.  For a spherical cell of radius r its effective permittivity εeff is 
given by:  
 
mm
mo
eff Cr
r
== φδ
εε
ε  (2) 
 
where δ is the membrane thickness, εo the permittivity of free space, εm is the mean relative 
permittivity of the material forming the membrane structure, and φm is the membrane-folding 
factor to take into account cell surface features such as folds, microvilli, ruffles and blebs27.  For 
a perfectly smooth spherical cell φm = 1.   
 
In the DEP literature7,14,27 it is commonly assumed that different values of Cm for different types 
of cell primarily reflect differences in the φm factor, and that the membrane thickness δ and 
relative permittivity εm in equation (2) remain relatively fixed in value (~5nm, 2.0-2.2, 
respectively27,28). However, recent DEP determination of Cm for fibroblasts and myoblasts, 
combined with Raman spectroscopic analyses of their membranes, has indicated that the 
chemical composition (e.g., proportion of saturated to unsaturated lipid content) may have a 
greater influence on the values for δ and εm than previously thought29.  
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Our study supports further development of DEP in the context of human embryonic stem cell 
bioprocessing, in the course of expansion or directed differentiation for industrial or therapeutic 
applications. The most tractable application would be for purposes of real-time monitoring of the 
representation of specific cell subpopulations through sampling limited quantities of cells at the 
time of passaging. This would not require large numbers of cells and could be implemented 
essentially using methods applied in this study. The application of DEP to the separation of 
relatively large numbers of cells (> 50,000) has been previously demonstrated (e.g., 13, 29).  
Scaled separation of tissue derived stem cells and differentiated progeny for further culture by 
such approaches will require process parallelization. 
 
IV. CONCLUSIONS 
 The various undifferentiated hESC lines (H1, H9, RCM1, RH1) and the transgenic clonal 
derivative (T8) studied in this work could not be discriminated in terms of their DEP cross-over 
frequencies and derived membrane capacitance values (14-20 mF/m2). However, the 
differentiated progeny (H1-MSC, H9-MSC, RCM1-trophoblast) could be discriminated from 
their adult precursors (H1, H9, RCM1, respectively) by significant increases in their mean DEP 
cross-over frequencies and derived membrane capacitance values.  The mesenchymal stem cell-
like phenotypes (H1-MSC, H9-MSC) derived from differentiation of H1 and H9 exhibited 
comparable Cm values of 41-49 mF/m2 (p<0.0001), whereas induction of RCM1 to a trophoblast 
cell-like phenotype resulted in a smaller increase of mean Cm values from 17.6 to 28.3 mF/m2 
(p<0.0001). Since different hESC lines were derived at different times in different laboratories, 
and have been cultured in different conditions at different times, yet Cm and fxo are similar, we 
conclude that a low membrane capacitance is a characteristic property of hESCs. Furthermore, 
the result that Cm changes upon differentiation suggests that different phenotypes might be 
discriminated by their Cm values. The transition to a larger membrane capacitance as the H9 cells 
differentiated to H9-MSCs was progressively evident after each passage of the cell culture up to 
p9 (Figure 8). All of these findings confirm the existence of distinctive parameters which differ 
between undifferentiated and differentiating hESCs, and suggests that dielectrophoresis can be 
applied in the manufacturing process of these cells.   
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The increase in membrane capacitance during differentiation could arise from an increase in the 
complexity of the membrane surface (appearance of folds, microvilli, blebs), or a combined 
thinning and increase of the effective dielectric polarisability of the membrane structure29. Which 
of these physico-chemical parameters contributes the most to the observed changes of membrane 
capacitance remains a focus of our ongoing studies.   
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Table 1: Flow cytometry analysis data for five undifferentiated hESC lines used in the study 
confirmed that comparable and high level of detection of SSEA-4 and TRA-1-60 and low levels 
of SSEA-1, as expected for this phenotype. Passage number at which cells assessed denoted by 
“p”. 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2: Summary of the data (cell diameter, DEP cross-over frequency (fxo) and membrane 
capacitance (Cm) obtained for the human embryonic stem cells and their differentiated progeny. 
 
Cell Type Diameter (µm) fxo (kHz) Cm (mF/m2) 
 
 
  H1  (n=206) 
 
14.5 ± 2.8 
 
68.4 ± 16.2 
 
16.1 ± 3.9 
  H9  (n=196) 11.1 ± 1.7 101.6 ± 25.8 14.2 ± 3.7 
  RCM1  (n=229) 14.2 ± 2.3 68.2 ± 22 17.6 ± 6.7 
  RH1  (n=254) 13.7 ± 1.6 63.8 ± 14.7 17.9 ± 3.9 
  T8  (n=134) 14.3 ± 2.0 55.6 ± 13.1 20.0 ± 5.3 
  H1-MSC  (n=98) 15.0 ± 3.1 26.1 ± 7.4 41.6 ± 11.0 
  H9-MSC  (n=185) 12.5 ± 2.2 26.2 ± 7.6 49.4 ± 12.2 
  RCM1-trophoblast (n=221) 12.8 ± 1.6 44.4 ± 11.8 28.3 ± 7.3  
 
 
 
 
 
 
 
hESC lines % marker positive 
 SSEA-1 SSEA-4 TRA1-60 
H1-p62 4 69 63 
H9-p73 2 85 75 
RCM1-p65 5 97 97 
RH1-p53 5 60 71 
T8-p98 3 32 66 
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Figure 1: (Top): Interdigitated electrode geometry used to determine the DEP cross-over 
frequency fxo.  (Bottom): COMSOL Multiphysics simulation of the DEP force (log10[N]) acting 
on a 10 µm diameter cell (Clausius-Mossotti factor = 0.5) with an applied voltage of 3 V(pk), as 
a function of distance (x µm) along and height above (z µm ) the electrode plane. 
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Figure 2:  Immunocytochemical confirmation of hESC and derivative lineages.  
Undifferentiated H1 hESCs (A) and MSC-like cells (B) and RCM-1 trophoblast-like cells (C, D) 
stained for OCT4 (A), MSC lineage markers CD105 (red) and Stro-1 (Green) (B) and 
trophoblast markers CDX2 (green, C) and hCG-β (green, D). Nuclei are counterstained with 
DAPI (blue) in all panels. Scale bar equals 20 µm. 
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Figure 3: Flow cytometric analysis of H1-MSC–like cells confirmed they were negative for 
CD14, CD34 and positive for CD105 (64%), CD90 (40%) CD73 (99%) and Stro1 (58%).  
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Figure 4: Differentiation potential of hyaluronan-generated hES-derived MSC-like cells. (A) 
H1HA cells differentiate along the ostoeogenic lineage to form mineralised bone when cultured 
in conditions conducive to osteogenesis (+OS) but not control conditions (-OS), as detected by 
alizarin red staining (red staining detectable from day 7 onwards). (B) Calcium deposition 
quantified by Sigma calcium assay kit from the experiment in A, shows that mineralised calcium 
only accumulates to detectable levels in osteogenic conditions (+OS, black bars). 
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Figure 5: (a) Percentage distributions of the DEP cross-over frequencies (fxo) measured for the 
different human embryonic stem cell lines. (b) The derived membrane capacitance (Cm) values.  
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Figure 6: Percentage distributions of the DEP cross-over frequencies (fxo) for (a) H1 and 
differentiated H1-MSC, (b) H9 and H9-MSC, (c) RCM1 and RCM1-trophoblast.   
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Figure 7: Membrane capacitance (Cm) values obtained for the human embryonic stem cells and 
their differentiated progeny. 
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Figure 8: The progression of (a) mean membrane capacitance Cm with 95 % confidence interval 
bars, and (b) mean cell diameter with 95% confidence interval error and passage number for the 
H9 cells cultured on an hyaluronan coated substrate. (**** and *** Signifies a statistical 
difference with p < 0.0001 and p < 0.001 between groups). 
 
